Clinical trial
Effects of Hypertonic Dextrose Prolotherapy on Conventional Physical Therapy in Patients With Subdeltoid Bursitis: a Double-blind, Randomized, Placebo-controlled Study
NCT05918146 is registered in ClinicalTrials.gov with Taipei Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Hypertonic Dextrose Prolotherapy on Conventional Physical Therapy in Patients With Subdeltoid Bursitis: a Double-blind, Randomized, Placebo-controlled Study
- Lead sponsor
- Taipei Medical University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- June 20, 2023
- Completion date
- June 30, 2024
- Enrollment
- 46 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
effect of drug, injection, subdeltoid bursitis